Back
Open Access

What are the implications of GLOBAL LEADERS for clinical practice?

Session: The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice
Topic: Other
Speaker: Professor K. Huber (Vienna, AT)
Event: Acute Cardiovascular Care 2019

Congress Session

0

About the speaker

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
40 presentations
6 followers

4 more presentations in this session

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice - Introduction.

Speaker: Professor P. Vranckx (Hasselt, BE)

Access
Slides
Video
0
Thumbnail

Design, statistics, and pitfalls of a pragmatic clinical trial.

Speaker: Professor K. Rowan (London, GB)

Access
Slides
Video
0
Thumbnail

Compliment the Investigators Assessment: the GLOBAL LEADERS Adjudication SubSTudy.

Speaker: Doctor A. Franzone (Naples, IT)

Access
Slides
0
Thumbnail

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice - Conclusion.

Speaker: Professor M. Valgimigli (Lugano, CH)

Access
Slides
0
Thumbnail

Access the full session

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice

Speakers: Professor K. Huber, Professor P. Vranckx, Professor K. Rowan, Doctor A. Franzone, Professor M. Valgimigli
Access
0
Thumbnail

About the event

Image

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

Congress
logo Image

This platform is supported by

logo Novo Nordisk